Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Adipocyte|January 24, 2022
The mechanisms underlying olanzapine-induced insulin resistance via the brown adipose tissue and the therapy in ratsJing Wang, Qian Wu, Yuan Zhou, et al.
Journal of Proteomics|November 11, 2019
Identification and characterization of proteins that are differentially expressed in adipose tissue of olanzapine-induced insulin resistance rat by iTRAQ quantitative proteomicsNi Yang, Liangyu Yu, Yahui Deng, et al.
Frontiers in Nutrition|August 22, 2022
Luteolin alleviates methionine-choline-deficient diet-induced non-alcoholic steatohepatitis by modulating host serum metabolome and gut microbiomeWei Guo, Lianxiang Luo, Yan Meng, et al.
Microbial Biotechnology|December 11, 2025
Akkermansia muciniphila Alleviates Olanzapine-Induced Hepatic Steatosis via the Gut Microbiota-IGFBP2/APOA1-Liver AxisJing Wang, Peiru Chen, Yahui Deng, et al.
Biochemical Pharmacology|May 24, 2024
miR-486-5p-rich extracellular vesicles derived from patients with olanzapine-induced insulin resistance negatively affect glucose-regulating functionChuyue Tu, Qian Wu, Jing Wang, et al.
Clinical and Experimental Pharmacology & Physiology|February 15, 2026
The TNF-α-FABP4-Dhhc7 Axis Mediates Olanzapine-Induced Insulin Resistance in Rats and HumansJing Wang, Peiru Chen, Chuyue Tu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 16, 2024
Gut microbiota of patients insusceptible to olanzapine-induced fatty liver disease relieves hepatic steatosis in ratsQian Wu, Jing Wang, Chuyue Tu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2019
Scaling up analogical innovation with crowds and AIAniket Kittur, Lixiu Yu, Tom Hope, et al.
Clinical Pharmacology in Drug Development|May 11, 2023
Pharmacokinetics and Pharmacodynamics of Lansoprazole/Sodium Bicarbonate Immediate-release Capsules in Healthy Chinese Subjects: An Open, Randomized, Controlled, Crossover, Single-, and Multiple-dose TrialLixiu Yu, Xuejia Zhai, Sanlan Wu, et al.
Cell Death & Disease|May 26, 2017
Activation of transient receptor potential vanilloid 4 involves in hypoxia/reoxygenation injury in cardiomyocytesQiong-Feng Wu, Cheng Qian, Ning Zhao, et al.
Pageof 3